Clinical characteristics of children and adults infected with severe acute respiratory syndrome coronavirus 2 Omicron variant BA.5 or BA.2

被引：0

作者：

付筱敏

机构：

[1] DeptInfectDis,Children'sHosp,FudanUniv,NatlChildren'sMedCenter

来源：

China Medical Abstracts(Internal Medicine) | 2024年 / 41卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R511.9 [];

学科分类号：

摘要：

<正>Objective To understand and compare the clinical characteristics of children and adults infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Omicron variant BA.5 and BA.2 subtypes in Shanghai City.

引用

页码：155 / 156

页数：2

共 50 条

[21] Virological Characteristics of Five SARS-CoV-2 Variants, Including Beta, Delta and Omicron BA.1, BA.2, BA.5
Zeng, Yan
Xia, Fei
Guo, Changfu
Hu, Chunxia
Li, Yuwei
Wang, Xiang
Wu, Qin
Chen, Zhuo
Lu, Jia
Wang, Zejun
VIRUSES-BASEL, 2023, 15 (12):
[22] Impact of BA.1, BA.2, and BA.4/BA.5 Omicron mutations on therapeutic monoclonal antibodies
Jawad, Bahaa
Adhikari, Puja
Podgornik, Rudolf
Ching, Wai-Yim
COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 167
[23] Reduced Pathogenicity and Transmission Potential of Omicron BA.1 and BA.2 Sublineages Compared with the Early Severe Acute Respiratory Syndrome Coronavirus 2 D614G Variant in Syrian Hamsters
Su, Wen
Choy, Ka Tim
Gu, Haogao
Sia, Sin Fun
Cheng, Ka Man
Nizami, Sarea Islam Nuha
Krishnan, Pavithra
Ng, Yuet Mai
Chang, Lydia Dai Jia
Liu, Yingzhi
Cheng, Samuel M. S.
Peiris, Malik
Poon, Leo L. M.
Nicholls, John M.
Yen, Hui Ling
JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (10): : 1143 - 1152
[24] Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England
Aziz, Nurin Abdul
Nash, Sophie Grace
Zaidi, Asad
Nyberg, Tommy
Groves, Natalie
Hope, Russell
Bernal, Jamie Lopez
Dabrera, Gavin
Thelwall, Simon
JOURNAL OF INFECTION, 2023, 87 (01) : E8 - E11
[25] Serum Neutralization of Omicron BA.5, BA.2 and BA.1 in Triple Vaccinated Kidney Transplant Recipients
Pedersen, Rune M.
Bang, Line L.
Tornby, Ditte S.
Nilsson, Anna C.
Nielsen, Christian
Madsen, Lone W.
Johansen, Isik S.
Sydenham, Thomas V.
Jensen, Thoger G.
Justesen, Ulrik S.
Vitved, Lars
Palarasah, Yaseelan
Bistrup, Claus
Andersen, Thomas E.
KIDNEY INTERNATIONAL REPORTS, 2023, 8 (03): : 667 - 671
[26] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
Touret, Franck
Baronti, Cecile
Pastorino, Boris
Villarroel, Paola Mariela Saba
Ninove, Laetitia
Nougairede, Antoine
de Lamballerie, Xavier
SCIENTIFIC REPORTS, 2022, 12 (01)
[27] In vitro activity of therapeutic antibodies against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5
Franck Touret
Cécile Baronti
Boris Pastorino
Paola Mariela Saba Villarroel
Laetitia Ninove
Antoine Nougairède
Xavier de Lamballerie
Scientific Reports, 12
[28] Distinct and relatively mild clinical characteristics of SARS-CoV-2 BA.5 infections against BA.2
Liping Guo
Xue Liu
Yuchen Gu
Jinyan Jiang
Ziyue Yang
Qiuying Lv
Deyin Guo
Yang Yang
Hongzhou Lu
Jing Yuan
Signal Transduction and Targeted Therapy, 8
[29] High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster
Guirakhoo, Farshad
Wang, Shixia
Wang, Chang Yi
Kuo, Hui-Kai
Peng, Wen-Jiun
Liu, Hope
Wang, Lixia
Johnson, Marina
Hunt, Adam
Hu, Mei Mei
Monath, Thomas P.
Rumyantsev, Alexander
Goldblatt, David
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (08): : 1401 - 1406
[30] Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
Wang, Xun
Ai, Jingwen
Li, Xiangnan
Zhao, Xiaoyu
Wu, Jing
Zhang, Haocheng
He, Xing
Zhao, Chaoyue
Qiao, Rui
Li, Minghui
Cui, Yuchen
Hu, Zixin
Xu, Chenqi
Zhang, Wenhong
Wang, Pengfei
CELL DISCOVERY, 2022, 8 (01)

← 1 2 3 4 5 →